BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 07/01/2025

FDA Releases Draft Guidance on Using Artificial Intelligence for Drug and Biological Product Regulation

The FDA has released a draft guidance to help the pharmaceutical industry use artificial intelligence to support regulatory decision-making for drug and biological products, aiming to improve public health.

Source: Federal Register — Food and Drug AdministrationOpen original release →